ArticleJournal of biochemical and molecular toxicology2026
E3 Ubiquitin Ligase NEDD4-Mediated CTSB Ubiquitination Prevents Microglial Ferroptosis After Subarachnoid Hemorrhage.
Article in Journal of biochemical and molecular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- E3 Ubiquitin Ligase NEDD4-Mediated CTSB Ubiquitination Prevents Microglial Ferroptosis After Subarachnoid Hemorrhage.Journal of biochemical and molecular toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To investigate the role of cathepsin B (CTSB) in microglial ferroptosis after subarachnoid hemorrhage (SAH) and its upstream regulatory mechanisms. A SAH mouse model was established, and BV2 microglial cell line was utilized. Gene expression was detected by qRT-PCR and western blot. Co-immunoprecipitation was performed to verify the interaction between NEDD4 and CTSB. CCK-8 and PI staining were used to evaluate cell viability and death. Immunofluorescence was employed to observe protein localization and oxidative stress marker levels. TUNEL staining was conducted to detect neuronal apoptosis. CTSB was specifically upregulated in microglia after SAH. CTSB knockdown significantly enhanced cell viability, reduced cell death, and reversed the abnormal changes in ferroptosis-related proteins and oxidative stress markers induced by hemin/RSL3. Mechanistically, NEDD4 was identified as an E3 ubiquitin ligase for CTSB, capable of directly binding and ubiquitinating CTSB protein for degradation. NEDD4 overexpression effectively reduced CTSB protein levels in SAH mouse brains while simultaneously alleviating brain edema, neuronal apoptosis, and neurological deficits, significantly inhibiting ferroptosis after SAH. NEDD4 attenuates secondary brain injury after SAH by ubiquitinating and degrading CTSB, thereby inhibiting microglial ferroptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.